Page last updated: 2024-12-06
acetyl hexamethyl indan
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phantolid: musk fragrance; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 47167 |
| SCHEMBL ID | 159738 |
| SCHEMBL ID | 11360760 |
| MeSH ID | M0102918 |
Synonyms (49)
| Synonym |
|---|
| ketone, 1,1,2,3,3,6-hexamethylindan-5-yl methyl |
| 5-acetyl-1,1,2,3,3,6-hexamethylindan |
| 15323-35-0 |
| nsc16827 |
| 6-acetyl-1,2,3,3,5-hexamethylindan |
| nsc-16827 |
| phantolide |
| ethanone,3-dihydro-1,1,2,3,3,6-hexamethyl-1h-inden-5-yl)- |
| 5-acetyl-1,2,3,3,6-hexamethylindan |
| ketone,1,2,3,3,6-hexamethyl-5-indanyl methyl |
| phantolid |
| ethanone, 1-(2,3-dihydro-1,1,2,3,3,6-hexamethyl-1h-inden-5-yl)- |
| ketone, 1,1,2,3,3,6-hexamethyl-5-indanyl methyl |
| 1-(1,1,2,3,3,6-hexamethyl-2h-inden-5-yl)ethanone |
| AKOS000623003 |
| 5-acetyl-1,1,2,3,3,6-hexamethylindane |
| 1-(2,3-dihydro-1,1,2,3,3,6-hexamethyl-1h-inden-5-yl)ethanone |
| 6-acetyl-1,1,2,3,3,5-hexamethyl indan |
| nsc 16827 |
| unii-3km1212j0y |
| 3km1212j0y , |
| einecs 239-360-0 |
| 1,1,2,3,3,6-hexamethylindan-5-yl methyl ketone |
| 6-acetyl-1,1,2,3,3,5-hexamethylindan |
| acetyl hexamethyl indan |
| ccris 8405 |
| phantolide (van) |
| FT-0673665 |
| 64058-43-1 |
| STL371299 |
| 1-(1,1,2,3,3,6-hexamethyl-2,3-dihydro-1h-inden-5-yl)ethanone |
| 1-(1,1,2,3,3,6-hexamethyl-2,3-dihydro-1h-inden-5-yl)ethan-1-one |
| SS-4365 |
| AKOS016340554 |
| 6-acetyl-1,1,2,3,3,5-hexamethylindane |
| ahdi |
| ahmi |
| acetyl hexamethyl indan [inci] |
| musk phantolid |
| BBL028589 |
| SCHEMBL159738 |
| DTXSID9051743 |
| SCHEMBL11360760 |
| mfcd00451399 |
| ahmi 10 microg/ml in cyclohexane |
| J-008993 |
| npd7834 |
| Q21099107 |
| CS-0328658 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.48
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.48) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||